Publishers & journalists
Verify names, source important claims, distinguish approved products from investigational compounds and link back to primary/regulatory records.
Explore the public evidence library and the structured data model underneath it. The current public product is the evidence system itself; software accounts, exports and API access are outside the present scope.
WhichPeps does not currently provide a paid professional product, account system or public API. This section makes the structured evidence infrastructure visible and inspectable without implying capabilities that are not available.
Verify names, source important claims, distinguish approved products from investigational compounds and link back to primary/regulatory records.
Move from canonical entities to structured human/preclinical evidence, study records, outcomes, routes, formulations and limitations.
Understand the schema, provenance and entity-resolution model behind the public pages before discussing any future structured access.
Use public evidence and methodology as a starting point for literature orientation, not as patient-specific clinical decision support.
Evidence status and effect direction are separate fields. A high-quality trial can support a null finding; a mechanistically interesting result can still sit at a low level of human certainty. The data model preserves both.
Monitoring, exports and machine-readable access may be developed later if there is demonstrated professional demand. Any later workflow should use the same schema and provenance rules as the public evidence pages.
Have a legitimate research, publishing or data use case? Email hello@whichpeps.com. This is a research and data-use contact route; no paid API or dashboard is currently offered.